Diabetes research startup thrives in OklahomaPublished: Sunday, October 20, 2019 By: Scott Meacham Source: NewsOK
When I set out last week to write about Aevus Precision Diagnostics, it was because this early stage startup has a compelling concept for tackling Type 2 diabetes (T2D).
As I heard more about Aevus co-founders — Puneet Chadha and Yash Sagar Santani — I recognized that their story is also a uniquely Oklahoma story, a story every Oklahoman should hear and repeat.
Puneet and Yash immigrated to the United States from India. Both achieved master’s degrees from Johns Hopkins University in Baltimore, Yash in finance, and Puneet in health/health care administration. Yash speaks five languages; Puneet is fluent in four.
After graduation, both accepted jobs in New York City — Yash in private equity and Puneet in health care consulting. They carried with them the idea for a diabetes drug therapy that they had researched and honed for business plan competitions while in school.
Read the story on NewsOK.com.